Search by Drug Name or NDC

    NDC 13925-0515-10 Pentamidine Isethionate 300 mg/300mg Details

    Pentamidine Isethionate 300 mg/300mg

    Pentamidine Isethionate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Seton Pharmaceuticals. The primary component is PENTAMIDINE ISETHIONATE.

    Product Information

    NDC 13925-0515
    Product ID 13925-515_8b18239a-6f0e-42ce-8411-d3d1819c131f
    Associated GPIs 16000045002130
    GCN Sequence Number 009599
    GCN Sequence Number Description pentamidine isethionate VIAL 300 MG INJECTION
    HIC3 W4K
    HIC3 Description ANTIPROTOZOAL DRUGS,MISCELLANEOUS
    GCN 42990
    HICL Sequence Number 004162
    HICL Sequence Number Description PENTAMIDINE ISETHIONATE
    Brand/Generic Generic
    Proprietary Name Pentamidine Isethionate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Pentamidine Isethionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 300
    Active Ingredient Units mg/300mg
    Substance Name PENTAMIDINE ISETHIONATE
    Labeler Name Seton Pharmaceuticals
    Pharmaceutical Class Antiprotozoal [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206666
    Listing Certified Through 2024-12-31

    Package

    NDC 13925-0515-10 (13925051510)

    NDC Package Code 13925-515-10
    Billing NDC 13925051510
    Package 10 VIAL in 1 TRAY (13925-515-10) / 300 mg in 1 VIAL
    Marketing Start Date 2018-04-01
    NDC Exclude Flag N
    Pricing Information N/A